Literature DB >> 14977362

Catecholates and mixed catecholate hydroxamates as artificial siderophores for mycobacteria.

Steffen Wittmann1, Lothar Heinisch, Ina Scherlitz-Hofmann, Thomas Stoiber, Dorothe Ankel-Fuchs, Ute Möllmann.   

Abstract

Different mono-, bis- or triscatecholates and mixed mono- or biscatecholate hydroxamates were synthesized as potential siderophores for mycobacteria. SiderOphore activity was tested by growth promotion assays using wild type strains and iron transport mutants of mycobacteria as well as Gram-negative bacteria. Some triscatecholates and biscatecholate hydroxamates were active in mutants of Mycobacterium smegmatis deficient in mycobactin and exochelin biosynthesis or exochelin permease, respectively, indicating an uptake route independent of the exochelin/mycobactin pathway. Structure activity relationships were studied. Ampicillin conjugates of some of these compounds were inactive against mycobacteria but active against Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977362     DOI: 10.1023/a:1024409517626

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  3 in total

1.  The design and synthesis of an antibacterial phenothiazine-siderophore conjugate.

Authors:  Abed Tarapdar; James K S Norris; Oliver Sampson; Galina Mukamolova; James T Hodgkinson
Journal:  Beilstein J Org Chem       Date:  2018-10-16       Impact factor: 2.883

Review 2.  Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?

Authors:  Kokob H Negash; James K S Norris; James T Hodgkinson
Journal:  Molecules       Date:  2019-09-11       Impact factor: 4.411

Review 3.  Mechanistic Insights and Potential Use of Siderophores Producing Microbes in Rhizosphere for Mitigation of Stress in Plants Grown in Degraded Land.

Authors:  Pratiksha Singh; Prabhat K Chauhan; Sudhir K Upadhyay; Rajesh Kumar Singh; Padmanabh Dwivedi; Jing Wang; Devendra Jain; Mingguo Jiang
Journal:  Front Microbiol       Date:  2022-07-11       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.